David Arkowitz Flexion Therapeutics Inc (FLXN) insider trading activity

FLXN Quotes by TradingView

David Arkowitz is Chief Financial Officer of Flexion Therapeutics Inc. Currently has a direct ownership of 220,719 shares of FLXN, which is worth approximately $2.02 Million. The most recent transaction as insider was on May 10, 2021, when has been sold 2,229 shares (Common Stock) at a price of $7.23 per share, resulting in proceeds of $16,116. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 221K
0% 3M change
0% 12M change
Total Value Held $2.02 Million

David Arkowitz Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 10 2021
SELL
Open market or private sale
$16,116 $7.23 p/Share
2,229 Reduced 1.0%
220,719 Common Stock
Mar 01 2021
BUY
Grant, award, or other acquisition
-
71,900 Added 24.39%
222,948 Common Stock
Jan 05 2021
SELL
Open market or private sale
$67,592 $11.13 p/Share
6,073 Reduced 3.87%
151,048 Common Stock

Also insider at

FSTX
F-star Therapeutics, Inc. Healthcare
Director
YMTX
YUMANITY THERAPEUTICS, INC. Healthcare
MCRB
Seres Therapeutics, Inc. Healthcare
Chief Financial Officer
IBIO
iBio, Inc. Healthcare
Director
DA

David Arkowitz

Chief Financial Officer
Cambridge, MA

Track Institutional and Insider Activities on FLXN

Follow Flexion Therapeutics Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FLXN shares.

Notify only if

Insider Trading

Get notified when an Flexion Therapeutics Inc insider buys or sells FLXN shares.

Notify only if

News

Receive news related to Flexion Therapeutics Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on FLXN